Paper · 38307029
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer.
Li Y and 19 others. Cell Rep Med, 2024. Cited by 36 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. Papers, record 38307029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38307029
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Microbiota | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Mice | |
| Animals | |
| Humans | |
| T-Lymphocytes | |
| Cell Communication | |
| Tumor Microenvironment |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AR069589 | NIAMS NIH HHS | United States | P30AR069589 | PubMed | NIH RePORTER |
| P01 CA247886 | NCI NIH HHS | United States | P01CA247886 | PubMed and NIH | NIH RePORTER |
| R01 CA197916 | NCI NIH HHS | United States | R01CA197916 | PubMed and NIH | NIH RePORTER |
| T32 CA009140 | NCI NIH HHS | United States | T32CA009140 | PubMed and NIH | NIH RePORTER |
| U54 CA268083 | NCI NIH HHS | United States | U54CA268083 | PubMed and NIH | NIH RePORTER |
| R01 CA245323 | NCI NIH HHS | United States | R01CA245323 | PubMed and NIH | NIH RePORTER |
| P30 AR069589 | NIAMS NIH HHS | United States | P30AR069589 | PubMed | NIH RePORTER |
| U01 CA224193 | NCI NIH HHS | United States | U01CA224193 | PubMed | NIH RePORTER |
| R21 CA264004 | NCI NIH HHS | United States | R21CA264004 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,398,337 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. | Cell | 2019 | https://conductscience.org/library/papers/31398337 | PubMed |
| 2 | 19,237,447 | ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19237447 | PubMed |
| 3 | 34,721,436 | The Mannose Receptor: From Endocytic Receptor and Biomarker to Regulator of (Meta)Inflammation. | Front Immunol | 2021 | https://conductscience.org/library/papers/34721436 | PubMed |
| 4 | 23,630,581 | phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. | PLoS One | 2013 | https://conductscience.org/library/papers/23630581 | PubMed |
| 5 | 29,961,579 | Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. | Cell | 2018 | https://conductscience.org/library/papers/29961579 | PubMed |
| 6 | 29,751,532 | The Role of the Polymeric Immunoglobulin Receptor and Secretory Immunoglobulins during Mucosal Infection and Immunity. | Viruses | 2018 | https://conductscience.org/library/papers/29751532 | PubMed |
| 7 | 28,475,899 | An Immune Atlas of Clear Cell Renal Cell Carcinoma. | Cell | 2017 | https://conductscience.org/library/papers/28475899 | PubMed |
| 8 | 28,474,673 | Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. | Nat Commun | 2017 | https://conductscience.org/library/papers/28474673 | PubMed |
| 9 | 16,199,517 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199517 | PubMed |
| 10 | 33,842,369 | The Role of CD276 in Cancers. | Front Oncol | 2021 | https://conductscience.org/library/papers/33842369 | PubMed |
1 to 10 of 53
See all 53 referencesCited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,957,626 | Autophagy and intratumoral bacteria abundance influence the prognosis of patients with pancreatic carcinoma. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42957626 | PubMed |
| 42,897,436 | Integrated Spatial and Bulk Transcriptomic Analysis Identifies a Multicellular Ecosystem Involved in Progression of Young Breast Cancer. | Cancer Med | 2026 | https://conductscience.org/library/papers/42897436 | PubMed |
| 42,840,628 | Intratumoral Microbiota in Fueling Cancer and Steering Treatment Response. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42840628 | PubMed |
| 42,699,280 | Microbiome-based diagnostic biomarkers in pancreatic ductal adenocarcinoma: Current evidence and translational challenges (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42699280 | PubMed |
| 42,640,483 | Microbiome and pancreatic ductal adenocarcinoma: mechanistic insights, microenvironmental interactions, and therapeutic implications. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42640483 | PubMed |
| 42,515,014 | Spatial Heterogeneity of Intratumoral Microbiota and Its Roles in Tumor-Microbiota Interactions and Therapeutic Implications. | Pathogens | 2026 | https://conductscience.org/library/papers/42515014 | PubMed |
| 42,429,613 | Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42429613 | PubMed |
| 42,224,953 | Advances in deciphering intratumoral versus peritumoral heterogeneity of infiltrating lymphocytes in pancreatic cancer: a spatial perspective. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42224953 | PubMed |
| 42,128,724 | Microbiome: a driver of pancreatic inflammation and tumorigenesis. | Trends Cancer | 2026 | https://conductscience.org/library/papers/42128724 | PubMed |
| 42,057,349 | Gut microbiota and pancreatic cancer: tumorigenesis, progression, and clinical applications. | Cancer Biol Med | 2026 | https://conductscience.org/library/papers/42057349 | PubMed |
1 to 10 of 29
See all 29 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38307029
GET https://conductscience.org/api/papers/v1/38307029/references?page=2